23 Jul, 2026
According to Straits Research, the global complementary and alternative medicine market size was valued at $275.52 billion in 2025 and is expected to grow from $347.43 billion in 2026 to $2,272.19 billion by 2034, registering a CAGR of 26.46% during the forecast period (2026–2034).
Complementary and Alternative Medicine (CAM) refers to a diverse range of medical practices, treatments, and therapies that are not typically part of conventional or mainstream medicine. CAM encompasses two primary approaches:
CAM therapies include a wide variety of practices, such as acupuncture, chiropractic care, herbal medicine, yoga, meditation, Ayurveda, traditional Chinese medicine (TCM), and naturopathy. These therapies emphasize holistic care, focusing on the mind, body, and spirit, and are often rooted in traditional healing systems from various cultures.
Increasing chronic pain rates and growing health consciousness drive the global market
The global landscape is witnessing a rising number of individuals experiencing chronic pain, which has significantly boosted the demand for non-pharmaceutical treatment options. Complementary and Alternative Medicine (CAM) therapies, such as acupuncture, have gained prominence for their effectiveness in managing pain.
This statistic highlights a critical trend in healthcare: the increasing necessity for alternative pain relief solutions. As more individuals seek holistic approaches to health, there is a clear shift toward integrating CAM therapies into mainstream treatment options, reflecting a broader movement toward preventive and personalized care.
Advancements in women's health research and development create tremendous opportunities
Advancements in research and development (R&D) for women’s health present substantial opportunities in the global market. The increasing demand for personalized and holistic healthcare solutions has created a pathway for companies to innovate within the women's wellness sector, which is experiencing heightened consumer interest. By concentrating on alternative therapies and natural health products that cater to the unique needs of women, businesses can effectively capitalize on this expanding market segment.
For instance, in March 2023, Gynoveda secured USD 10 million in funding to enhance its R&D initiatives. The company aims to develop Ayurvedic products specifically tailored for women’s health by merging traditional Ayurvedic practices with modern scientific research. This strategic approach positions Gynoveda to meet individual health requirements, offering natural and effective solutions that align with the rising demand for holistic care. Such targeted R&D initiatives underscore the significant growth potential within the CAM market, particularly as companies focus on innovative solutions for women’s health.
Europe is the most significant global complementary and alternative medicine market shareholder, driven by strategic initiatives that integrate traditional therapies into cancer treatment. The strong demand for complementary therapies, particularly among cancer patients, underscores the need for greater accessibility to holistic options. Moreover, efforts to enhance patient quality of life through the incorporation of therapies like acupuncture and herbal medicine are gaining momentum in European countries, improving overall well-being and alleviating treatment side effects.
The Asia Pacific region is experiencing a rapid growth rate in the market, spurred by increasing health awareness and rising incidences of chronic diseases. Consumers are actively seeking holistic and preventive healthcare solutions, driving demand for complementary therapies. Moreover, several initiatives in APAC are developed that are aimed at fostering collaboration between modern and traditional medical practices to promote integrative health approaches, reinforcing the focus on holistic well-being.
sales@straitsresearch.com